Thus, the aim of this work was to present new diagnostic tools, potentially suitable for IVD certification—an antibody for the detection of CA IX in IHC and an ELISA kit for the detection of sCA IX in plasma—whose diagnostic properties we verified on a cohort of 100 patients with BC. The gene discussed is CA9; the disease is breast cancer.